At a time when the 340B program is under increasing pressure, Advocates for Community Health (ACH) is stepping forward to help guide the path ahead. Last week, Advocates for Community Health (ACH) officially kicked off its 340B Learning Collaborative, bringing together health center 19 leaders from 15 states for a focused, solutions-driven effort to strengthen […]
In this episode of Community Health Centers Unfiltered, Advocates for Community Health goes beyond the headlines to explore how federal health policy is actually made — and what that process means for the stability and sustainability of community health centers (CHCs). Co-Host Margaret French of Venn Strategies is joined by Debbie Curtis and Rodney Whitlock […]
The federal healthcare landscape is shifting rapidly, but community health centers (CHCs) continue to demonstrate how community-driven primary care can meet the moment. That was the clear message from Advocates for Community Health’s 5th Annual Member Meeting, where health center leaders, federal officials, and policymakers gathered in Washington to chart the next chapter in health […]
ACH’s SVP of Policy & Government Affairs Stephanie Krenrich was featured in this article today on the 340B Rebate Model from Bridget Early at Modern Healthcare: “Drugmakers are upping their demands for transparency in the 340B Drug Pricing Program by imposing new requirements that have sparked ire among safety-net providers,” reports Bridget Early. “Novo Nordisk […]
ACH sent a letter to U.S. Congressional leaders outlining a path toward a stronger, more sustainable healthcare system. The letter details ACH’s main policy priorities: long-term, robust investment in the Community Health Center Fund; protection of the 340B Program from harmful rebate models; reinvestment in the primary care workforce, especially the National Health Service Corps; and […]
“340B provider advocates, attorneys and program consultants offered largely mixed reactions Tuesday to the Health Resources Services and Administration’s (HRSA) reconsideration of 340B rebates following a federal court ruling that blocked the Trump administration’s initial rebate model from taking effect last month,” writes Shannon Young at 340B Report. HRSA is soliciting comments from stakeholders on […]
As Congress considers reforms to the 340B Drug Pricing Program, Advocates for Community Health (ACH) has taken an active role in shaping policy proposals that reflect the operational realities of community health centers and prioritize patient access. Through sustained engagement with lawmakers around its innovative 340C legislative framework, ACH has helped advance reform concepts that […]
In a letter to HRSA, ACH urged the agency to prohibit Eli Lilly from requiring claims-level data to access 340B drug pricing. This unilateral requirement acts as an unauthorized audit and imposes severe administrative burden on community health centers that are already facing unprecedented fiscal strain. The change threatens critical funding used to deliver care […]
ACH submitted comments to U.S. Congressional Doctors’ Caucuses outlining feedback on proposed payment reforms to improve costs and quality of care. The letter outlines support for Medicaid-focused value-based care models and a temporary 10% Medicare PPS payment add-on to help fund critical technology infrastructure. Read ACH’s comment letter
Shannon Young at 340B Report writes: “340B program stakeholders offered varying reactions following a late-December federal court ruling that halted the controversial rebate pilot from taking effect as planned, with providers celebrating the judge’s temporary pause, while the federal government and some drugmakers pushed back against the order.” Advocates for Community Health (ACH) spokesperson Sandy […]
